Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Mottet

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
European Urology|August 30, 2008
Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspectiveNicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Epidemiology of penile cancer]Nicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Epidemiology of testicular cancer]Nicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Scrotal self-examination]Nicolas Mottet
European Urology Oncology|June 4, 2019
Multiparametric Magnetic Resonance Imaging Cost-effectiveness in Active Surveillance: More a Belief than EvidenceNicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Risk factors for testicular cancer and carcinogenesis mechanisms]Nicolas Mottet
European Urology Focus|July 21, 2017
Metastatic Castration-resistant Prostate Cancer: Major Progress Leading to Even More QuestionsNicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 31, 2008
[Cancer of the penis: Association Française d'Urologie Cancer Committee guidelines]Nicolas Mottet
Current Opinion in Urology|May 14, 2013
Results of hormone therapy as first-line treatment for high-risk prostate cancerNicolas Mottet
European Urology|July 16, 2014
Intermittent androgen deprivation therapy with antagonist: really new information?Nicolas Mottet
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
European Urology|August 30, 2008
Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspectiveNicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Epidemiology of penile cancer]Nicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Epidemiology of testicular cancer]Nicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Scrotal self-examination]Nicolas Mottet
European Urology Oncology|June 4, 2019
Multiparametric Magnetic Resonance Imaging Cost-effectiveness in Active Surveillance: More a Belief than EvidenceNicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 9, 2005
[Risk factors for testicular cancer and carcinogenesis mechanisms]Nicolas Mottet
European Urology Focus|July 21, 2017
Metastatic Castration-resistant Prostate Cancer: Major Progress Leading to Even More QuestionsNicolas Mottet
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 31, 2008
[Cancer of the penis: Association Française d'Urologie Cancer Committee guidelines]Nicolas Mottet
Current Opinion in Urology|May 14, 2013
Results of hormone therapy as first-line treatment for high-risk prostate cancerNicolas Mottet
European Urology|July 16, 2014
Intermittent androgen deprivation therapy with antagonist: really new information?Nicolas Mottet
Pageof 22